Humana Inc. (HUM) is projected to report a loss of $4.01 per share on revenues of $31.9 billion for its fourth-quarter 2025 earnings, leading to a potential year-over-year decline in its bottom line. While premiums and service revenues are expected to increase, a forecasted 7.6% year-over-year decline in medical membership and a 9.7% decrease in operating income from the Insurance unit are likely to negatively impact results. The company currently holds a Zacks Rank #4 (Sell) and an Earnings ESP of 0.00%, suggesting it may not beat earnings estimates this quarter.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Will Declining Medical Membership Affect Humana's Q4 Earnings?
Humana Inc. (HUM) is projected to report a loss of $4.01 per share on revenues of $31.9 billion for its fourth-quarter 2025 earnings, leading to a potential year-over-year decline in its bottom line. While premiums and service revenues are expected to increase, a forecasted 7.6% year-over-year decline in medical membership and a 9.7% decrease in operating income from the Insurance unit are likely to negatively impact results. The company currently holds a Zacks Rank #4 (Sell) and an Earnings ESP of 0.00%, suggesting it may not beat earnings estimates this quarter.